Protein
Protein quality and leucine thresholds: the per-meal anabolic signal
Muscle protein synthesis is driven primarily by reaching a leucine threshold per meal. What that means for protein-source choice and per-meal portion size on GLP-1.
The protein-target framework on this site references “the leucine threshold” multiple times. This article unpacks what the leucine threshold actually is, why it matters specifically on GLP-1, and what per-meal portion sizes reach it.
The leucine threshold concept
Muscle protein synthesis (MPS) — the molecular process by which muscle tissue is built or maintained — is stimulated by amino acids in the bloodstream, with leucine specifically acting as the primary trigger. The relationship is not linear: there is a threshold below which MPS is barely stimulated and above which MPS rises to a near-maximal rate. Above the threshold, additional protein produces only modest additional MPS stimulation.
The threshold is approximately 2.5-3 g of leucine per meal in healthy adults. Older adults may have a slightly higher threshold (anabolic resistance); the practical implication is that older adults benefit more reliably from per-meal portions toward the upper end of the threshold range.
Why this matters specifically on GLP-1
GLP-1 receptor agonist therapy reduces meal capacity. A patient who could eat a 8-oz steak before initiation may find that a 4-oz portion is now their limit. The practical question becomes: at the meal sizes the patient can actually consume, is each meal reaching the leucine threshold?
If the patient is consuming 4 small meals per day, each at 18 g of mixed protein (well below the threshold), MPS may be stimulated minimally despite a respectable total daily protein intake of 72 g. The same 72 g distributed as 3 meals at 24 g each, hitting the threshold each time, produces more MPS stimulation. The same 72 g concentrated in 2 meals at 36 g each produces 2 maximal MPS pulses but a longer interval between pulses (which may matter less than reaching the threshold but is the basis for the “4-5 evenly distributed meals” recommendation).
Leucine content of common protein sources
| Source | Leucine % of protein | Approximate protein needed per meal to reach 2.5-3 g leucine |
|---|---|---|
| Whey | ~10-11% | ~25-28 g |
| Egg white | ~9% | ~28-33 g |
| Whole egg | ~8-9% | ~30-35 g |
| Beef, lean | ~8% | ~30-37 g |
| Chicken breast | ~8% | ~30-37 g |
| Fish (white) | ~8% | ~30-37 g |
| Casein | ~9-10% | ~28-33 g |
| Greek yogurt | ~8-9% | ~30-37 g |
| Cottage cheese | ~10% | ~25-30 g |
| Soy isolate | ~8% | ~30-37 g |
| Pea protein isolate | ~7-8% | ~32-40 g |
| Rice protein isolate | ~7% | ~36-43 g |
| Hemp protein | ~6% | ~42-50 g |
| Quinoa (cooked) | ~6% | ~42-50 g |
Animal-source proteins and soy isolate reach the threshold at smaller per-meal portions. Other plant proteins typically require larger per-meal portions or strategic combination.
What the older-adult threshold looks like
Older adults (>65) with anabolic resistance may benefit from per-meal portions in the 35-40 g range from animal sources, or proportionally larger plant-source portions. This corresponds to approximately 3-3.5 g of leucine per meal. The PROT-AGE recommendations (Bauer et al. 2013) reflect this in the higher daily protein-target range for older adults (1.4-1.8 g/kg LBM rather than 1.2-1.6 g/kg LBM).
Practical implications
The protein-target framework on this site can be summarized in three layers:
- Total daily protein in the 1.2-1.6 g/kg LBM range (1.4-1.8 for older adults).
- Distributed across 4-5 eating occasions when meal capacity allows.
- With each occasion ideally reaching the leucine threshold (~25-30 g animal protein, ~35-45 g plant protein).
When meal capacity does not allow a full leucine-threshold portion at one of the eating occasions, the practical adjustment is to either (a) accept that occasion as sub-threshold and reach the threshold at the other occasions, or (b) supplement that occasion with a small whey or plant-isolate addition to lift it above threshold.
Free-form leucine supplementation
Leucine itself is available as a supplement. There is some evidence supporting free-form leucine addition to lower-protein meals to lift them above the MPS threshold, but the practice is more relevant to performance-nutrition contexts than to general GLP-1 nutrition. Discuss with your dietitian; this is “marginal additional optimization” not “essential.”
Common questions
“Is the leucine threshold the same as a ‘protein target’?” No. The protein target is the daily total. The leucine threshold is a per-meal concept. Both matter; they are separate variables.
“Do BCAAs help?” Branched-chain amino acid (BCAA) supplements include leucine but isolating them does not produce greater MPS than reaching threshold via complete protein. BCAAs in addition to adequate protein add little; BCAAs as a substitute for complete protein are inferior.
“What if I am already exceeding the daily target?” Total daily protein remains the most important variable. Patients comfortably exceeding their daily target with a reasonable distribution across the day do not generally need further leucine-threshold optimization.
References
- Norton LE, Layman DK. Leucine regulates translation initiation of protein synthesis in skeletal muscle after exercise. Journal of Nutrition. 2006;136(2):533S-537S.
- Phillips SM, Chevalier S, Leidy HJ. Protein “requirements” beyond the RDA. Applied Physiology, Nutrition, and Metabolism. 2016;41(5):565-572.
- Bauer J, Biolo G, Cederholm T, et al. Evidence-based recommendations for optimal dietary protein intake in older people. Journal of the American Medical Directors Association. 2013;14(8):542-559.
- Witard OC, Jackman SR, Breen L, Smith K, Selby A, Tipton KD. Myofibrillar muscle protein synthesis rates subsequent to a meal in response to increasing doses of whey protein at rest and after resistance exercise. American Journal of Clinical Nutrition. 2014;99(1):86-95.
- Cuthbertson D, Smith K, Babraj J, et al. Anabolic signaling deficits underlie amino acid resistance of wasting, aging muscle. FASEB Journal. 2005;19(3):422-424.